Kuros Biosciences AG at the Annual general meeting approved Board of director and committee changes. Albert Arp and Chris Fair (CEO) were elected as new members of the Board of Directors, Albert Arp was elected as a new member of the Compensation Committee. Scott Bruder did not stand for re-election as member of the board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.48 CHF | +1.25% | -20.20% | +85.67% |
Apr. 24 | Kuros Biosciences Posts Higher Q1 Product Sales | MT |
Apr. 17 | Kuros Biosciences AG Approves Board of Director and Committee Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+85.67% | 260M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- KURN Stock
- News Kuros Biosciences AG
- Kuros Biosciences AG Approves Board of Director and Committee Changes